James Sherblom

Insider Reports History

Entity
Individual
Location
12 Gill Street, Suite 4650, Woburn, MA
Signature
/s/ Ryan M. Rourke Reed, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by James Sherblom:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Comera Life Sciences Holdings, Inc. Director Common Stock 452K $32K $0.07 Jan 4, 2023 Direct
Comera Life Sciences Holdings, Inc. Director Warrant (Right to Buy) 81.1K $20.3K $0.25 Jan 4, 2023 Direct
Comera Life Sciences Holdings, Inc. Director Warrants (right to buy) 81.1K $20.3K $0.25 Jan 4, 2023 Direct
Comera Life Sciences Holdings, Inc. Director Stock Option (Right to Purchase) 104K Nov 9, 2023 Direct
Comera Life Sciences Holdings, Inc. Director Stock Option (Right to Buy) 36.2K May 19, 2022 Direct

Insider Reports Filed by James Sherblom

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CMRA Comera Life Sciences Holdings, Inc. Nov 9, 2023 1 $0 4 Nov 14, 2023 Director
CMRA Comera Life Sciences Holdings, Inc. Aug 31, 2023 1 $0 4 Sep 1, 2023 Director
CMRA Comera Life Sciences Holdings, Inc. May 12, 2023 1 $0 4 May 16, 2023 Director
CMRA Comera Life Sciences Holdings, Inc. Feb 14, 2023 1 $0 4 Feb 16, 2023 Director
CMRA Comera Life Sciences Holdings, Inc. Jan 4, 2023 2 $120K 4/A Feb 14, 2023 Director
CMRA Comera Life Sciences Holdings, Inc. Dec 31, 2022 1 $0 5 Feb 14, 2023 Director
CMRA Comera Life Sciences Holdings, Inc. Sep 12, 2022 1 $102K 4 Sep 12, 2022 Director
CMRA Comera Life Sciences Holdings, Inc. May 19, 2022 0 $0 3 May 20, 2022 Director